| Uterine Corpus Carcinosarcoma studied in …STUDIED_INderived15 of 15show fewer |
|---|
| → studied in | NCT05256225Phase 3 · recruiting Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma · condition mapped ONTOLOGY_EXACT · 15 trials mapped (7 active) | — | — | Uterine Corpus Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03651206Phase 2/Phase 3 · recruiting Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib · condition mapped ALIAS · 15 trials mapped (7 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07741968NA · recruiting A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer · condition mapped ONTOLOGY_EXACT · 15 trials mapped (7 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03120624Phase 1 · active not recruiting VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer · condition mapped CURATED_BROADER · 15 trials mapped (7 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05049538recruiting Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers · condition mapped ONTOLOGY_EXACT · 15 trials mapped (7 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05156268Phase 2 · completed A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma · condition mapped ALIAS · 15 trials mapped (7 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02874430Phase 2 · terminated Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer · condition mapped ONTOLOGY_EXACT · 15 trials mapped (7 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03422198Phase 3 · recruiting Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 15 trials mapped (7 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04106414Phase 2 · active not recruiting Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment · condition mapped ALIAS · 15 trials mapped (7 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01935934Phase 2 · completed Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 15 trials mapped (7 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04906382early Phase 1 · terminated Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer · condition mapped CURATED_BROADER · 15 trials mapped (7 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05001282Phase 1/Phase 2 · terminated A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) · condition mapped ALIAS · 15 trials mapped (7 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02020707Phase 1 · completed Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers · condition mapped ONTOLOGY_EXACT · 15 trials mapped (7 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03015129Phase 2 · completed A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer · condition mapped ALIAS · 15 trials mapped (7 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00478426Phase 2 · completed Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 15 trials mapped (7 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |